Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$12.50 USD
-0.34 (-2.65%)
Updated May 8, 2024 04:00 PM ET
After-Market: $12.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Liquidia Technologies, Inc. [LQDA]
Reports for Purchase
Showing records 121 - 128 ( 128 total )
Company: Liquidia Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Liquidia Technologies, Inc.
Industry: Medical - Biomedical and Genetics
LIQ861 Positive Two-week Safety Data Supports NDA Filing in Late 2019
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Liquidia Technologies, Inc.
Industry: Medical - Biomedical and Genetics
LIQ865 Shows Signs of Clinical Efficacy for Local Pain Relief
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Liquidia Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Liquidia Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Looking Ahead to LIQ861 Phase 3 Two-Week Safety Data in Q1
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Liquidia Technologies, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Liquidia Technologies, Inc.
Industry: Unclassified
Initiating at OUTPERFORM: Improving Therapies with Particle Engineering
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Liquidia Technologies, Inc.
Industry: Unclassified
Initiating at OUTPERFORM: Improving Therapies with Particle Engineering
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L